About
Atlas Genetics, now rebranded as binx health, is an in vitro diagnostics company focused on decentralized, near-patient, and point-of-care testing solutions. The company aims to enhance healthcare outcomes for women and families worldwide through its proprietary technology platform, which allows for rapid and cost-effective diagnosis of infectious diseases, delivering results in 30 minutes or less. Their flagship product, the io® platform, is a sample-to-answer system designed for quick PCR detection of infectious diseases, particularly sexually transmitted infections like chlamydia and gonorrhea. In addition to point-of-care testing devices, binx health is expanding into mobile and digital health solutions to facilitate at-home testing. These innovations aim to increase patient access to testing under the supervision of licensed physicians, providing convenient care options in various settings such as homes, retail pharmacies, and workplace wellness fairs. The company is supported by notable investors, including Novartis Venture Fund and Johnson & Johnson Innovation, reflecting strong confidence in its technology and market potential.
Technologies
Keywords
Company Information
-
Employees 8
-
Founded 2005
-
Annual Revenue $7000000
-
Total Funding $84704041
Location
75 Francis Street, Boston, Massachusetts, United States, 02115
